Neurofeedback Systems Market By Type (Frequency Neurofeedback System, Low Energy Neurofeedback System, Slow Cortical Potential Neurofeedback System, Hemoencephalographic Neurofeedback System, Low Resolution Electromagnetic Tomography and Functional Magnetic Resonance Imaging (fMRI)), By Application (Attention Deficit Hyperactivity Disorder (ADHD), Epilepsy, Anxiety, Insomnia, Migraine, Drug Addiction and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The neurofeedback systems market is set to reach from US$ 820.7 Mn in 2017 to US$ 1,565.6 Mn by 2026 at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2018 to 2026. According to the latest research findings published in Lancet by the Global Burden of Disease (GBD), neurological disease are the leading cause of death and disability worldwide. Neurofeedback system is also called as EEG biofeedback system is a noninvasive type of brain training system. It employs electrodes to record and modulate brain waves in the treatment of neurological diseases.

Market Synopsis 

Get a sample copy for more information

"Simplicity and popularity among neurologist drives the market growth for frequency neurofeedback system"

Frequency neurofeedback system is currently reigning the type segment for neurofeedback systems market. The key features contributing to its positive growth are its ease and simplicity to operate and popularity among neurologist. It uses 2 to 4 surface electrodes and so is popularly called as surface neurofeedback. It is employed to change the speed and amplitude of specific brain waves for the treatment of neurological disorders such as ADHD, insomnia and anxiety. Functional magnetic resonance imaging (fMRI) is the latest neurofeedback system which is employed to modulate brain activity from deep subcortical brain region. It is the most effective method used in the planning and execution of epilepsy surgery.

Get a sample copy for more information

"Increasing prevalence rate and significant rise in the patients showing resistance to medication drive the market growth for epilepsy"

Epilepsy is currently dominating the application segment for neurofeedback systems market. 50 million people throughout the globe are suffering with epilepsy making it the most common neurological disease. It causes social discrimination and stigma to people suffering with epilepsy. There has been a significant increase in the number of patients showing resistance to medication. In epilepsy the brain continuously misfires signals, hence neurofeedback modulates the brain to inhibit slow waves and promote mid-range frequencies which eventually prevents seizures. Attention deficit hyperactivity disorder (ADHD) has garnered a lot of attention in the last decade. Medications such as Concerta, Ritalin and Dexedrine have been used as long term treatment for ADHD, evidence have reported with severe adverse effects associated with this medication such as anxiety, insomnia and decreased appetite. Neurofeedback therapy decreases the brain activity in theta band region and promotes activity in beta band region in patients suffering with ADHD.

Get a sample copy for more information

"Rising prevalence of neurological disorders and existence of advanced healthcare infrastructure drive the market growth in North America"

North America currently holds a share of 60% in the neurofeedback systems market. The major features responsible for its dominance in global neurofeedback systems market are rising prevalence of neurological disorders and existence of advanced healthcare infrastructure. As per the statistics provided by Center for Disease Control and Prevention (CDC), there are approximately 3.4 million U.S. citizens suffering with active epilepsy. Europe is the second largest market with a share of 20% on account of large population base suffering with insomnia and anxiety. Several patients are showing resistance to medication and are seeking EEG based therapies to change the brainwaves to counteract ADHD, epilepsy and migraine. Asia Pacific represents a share of 8% and is set to register impressive growth during the forecast period from 2018 to 2026 on account of developing health infrastructure and rampant growth in neurological diagnosis and treatment.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market segmentation comprises of by type, application and geography.

Medical device manufacturers producing EEG equipment for neurofeedback systems are BrainMaster Technologies, Inc., BEE Medic GmbH, Mind Media B.V., Mitsar Co., Ltd., Myndlift, Neurobit Systems, NeuroCare Group GmbH, Stens Corporation, Thought Technology Ltd. and Wearable Sensing.

Key questions answered in this report

• Which major players are active in the neurofeedback systems market?
• What are the latest technological advancement in the EEG devices and how effective are they in modulating abnormal brain waves?
• What is the disease etiology of common brain illness and how effective is neurofeedback systems in their treatment?
• What is FMRI and how is it employed in the treatment of epileptic surgical procedures?
• What is ADHD and what is the treatment regimen employed?
• Which factors are responsible for the dominance of North America in global neurofeedback systems market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global NS Market Portraiture
2.2. Global NS Market, by Type, 2017 (US$ Mn)
2.3. Global NS Market, by Application, 2017 (US$ Mn)
2.4. Global NS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Neurofeedback Systems (NS) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global NS Market, by Key Players, 2017

Chapter 4. Global Neurofeedback Systems (NS) Market, by Type
4.1. Overview
4.2. Frequency Neurofeedback System (FNS)
4.3. Low Energy Neurofeedback System (LENS)
4.4. Slow Cortical Potential Neurofeedback System (SCP-NF)
4.5. Hemoencephalographic Neurofeedback System (HEG)
4.6. Low Resolution Electromagnetic Tomography (LORE-TA)
4.7. Functional Magnetic Resonance Imaging (fMRI)

Chapter 5. Global Neurofeedback Systems (NS) Market, by Application
5.1. Overview
5.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.3. Epilepsy
5.4. Anxiety
5.5. Insomnia
5.6. Migraine
5.7. Drug Addiction
5.8. Others

Chapter 6. Global Neurofeedback Systems (NS) Market, by Geography
6.1. Overview
6.2. North America NS Market Analysis, 2016 – 2026
6.2.1. North America NS Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America NS Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America NS Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe NS Market Analysis, 2016 – 2026
6.3.1. Europe NS Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe NS Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific NS Market Analysis, 2016 – 2026
6.4.1. Asia Pacific NS Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific NS Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America NS Market Analysis, 2016 – 2026
6.5.1. Latin America NS Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America NS Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa NS Market Analysis, 2016 – 2026
6.6.1. MEA NS Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA NS Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. BrainMaster Technologies, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. BEE Medic GmbH
7.3. Mind Media B.V.
7.4. Mitsar Co., Ltd.
7.5. Myndlift
7.6. Neurobit Systems
7.7. NeuroCare Group GmbH
7.8. Stens Corporation.
7.9. Thought Technology Ltd.
7.10. Wearable Sensing.

* NS - Neurofeedback Systems

FIG. 1 Neurofeedback Systems (NS) Market: Research Methodology
FIG. 2 NS Market Segmentation
FIG. 3 Global NS Market, by Type, 2017 (US$ Mn)
FIG. 4 Global NS Market, by Application, 2017 (US$ Mn)
FIG. 5 Global NS Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global NS Market, by Key Players, 2017
FIG. 8 Global Frequency NS Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Low Energy NS Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Slow Cortical Potential NS Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Hemoencephalographic NS Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Low Resolution Electromagnetic Tomography NS Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Functional Magnetic Resonance Imaging NS Market, 2016 – 2026 (US$ Mn)
FIG. 14 Global Attention Deficit Hyperactivity Disorder Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 15 Global Epilepsy Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 16 Global Anxiety Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 17 Global Insomnia Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 18 Global Migraine Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 19 Global Drug Addiction Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 20 Global Other Applications Market for Neurofeedback Systems, 2016 – 2026 (US$ Mn)
FIG. 21 U.S. NS Market, 2016 – 2026 (US$ Mn)
FIG. 22 Canada NS Market, 2016 – 2026 (US$ Mn)
FIG. 23 U.K. NS Market, 2016 – 2026 (US$ Mn)
FIG. 24 Germany NS Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Europe NS Market, 2016 – 2026 (US$ Mn)
FIG. 26 China NS Market, 2016 – 2026 (US$ Mn)
FIG. 27 Japan NS Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Asia Pacific NS Market, 2016 – 2026 (US$ Mn)
FIG. 29 Brazil NS Market, 2016 – 2026 (US$ Mn)
FIG. 30 Mexico NS Market, 2016 – 2026 (US$ Mn)
FIG. 31 Rest of Latin America NS Market, 2016 – 2026 (US$ Mn)
FIG. 32 GCC NS Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest of MEA NS Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Neurofeedback Systems (NS) Market Portraiture
TABLE 2 Global NS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global NS Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global NS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America NS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America NS Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America NS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe NS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe NS Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific NS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific NS Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America NS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America NS Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa NS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa NS Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa NS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 BrainMaster Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 BEE Medic GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Mind Media B.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Mitsar Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Myndlift: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Neurobit Systems: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 NeuroCare Group GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Stens Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Thought Technology Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Wearable Sensing: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)